Pancreastatin, a Regulatory Peptide Derived From Chromogranin A☆
-
Add time:08/27/2019 Source:sciencedirect.com
Pancreastatin (PST) is a biologically active peptide isolated first from porcine pancreas. Its origin takes place in chromogranin A proteolysis within the neuroendocrine and gastrointestinal systems. Although ample metabolic effects, such as modulation of secretion of different glands, as well as general metabolism regulation, have been described, the putative physiological role of PST has not yet been established. This article seeks to describe the synthesis and secretion of PST as well as its biological activities in a number of tissues.
We also recommend Trading Suppliers and Manufacturers of pancreastatin-29 (cas 113817-19-9). Pls Click Website Link as below: cas 113817-19-9 suppliers
Prev:Southern surgical association articleElevated Plasma Pancreastatin, but Not Chromogranin A, Predicts Survival in Neuroendocrine Tumors of the Duodenum
Next:ReviewComprehensive review on tumour active palladium compounds and structure–activity relationships) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Southern surgical association articleElevated Plasma Pancreastatin, but Not Chromogranin A, Predicts Survival in Neuroendocrine Tumors of the Duodenum08/26/2019
- Pancreastatin inhibitor activates AMPK pathway via GRP78 and ameliorates dexamethasone induced fatty liver disease in C57BL/6 mice08/25/2019
- Original articleThe occurrence of pancreastatin in tumours of the diffuse neuroendocrine system08/24/2019
- ArticleChromogranin A(210–301) is the major form of pancreastatin-like material in human gut extracts and endocrine tumors08/23/2019
- ArticleEffects of synthetic human pancreastatin on pancreatic secretion and blood flow in rats and dogs08/22/2019
